Previous evaluations of the Bac-T-Screen system (Vitek Systems, Inc., Hazelwood, Mo.) demonstrated excellent sensitivity with specimens from patients with clinically significant bacteriuria (including infections with small numbers of uropathogens) but poor specificity with specimens from noninfected patients. In the study reported here, the sensitivity and specificity of the Bac-T-Screen system with a modified decolorizing reagent were evaluated. A manual filtration system, FiltraCheck-UTI (Vitek Systems), for screening urine specimens, Gram stains of mixed urine specimens, and quantitative cultures were also evaluated. The test sensitivity for clinically significant bacteriuria was >96% with the original Bac-T-Screen system as well as the modified system and the manual system. In comparison, the sensitivities of the Gram stains and quantitative cultures (-105 CFU/ml) were 82 and 77%, respectively. Of the 375 patients classified as noninfected by clinical parameters, 34% had positive screening tests with the original Bac-T-Screen system, as compared with 13 and 11% with the modified Bac-T-Screen and FiltraCheck-UTI systems, respectively. Thus, the modified Bac-T-Screen system and the manual FiltraCheck-UTI system have sensitivities comparable to that of the original Bac-T-Screen system and markedly improved test specificities.
A number of urine screening systems, including methods that are growth dependent (e.g., automated systems that measure microbial growth as increases in turbidity in a broth culture) and growth independent (e.g., microscopic and enzymatic tests), have been developed. One growth-independent screening method for bacteriuria is the Bac-TScreen (BTS) system (Vitek Systems, Inc., Hazelwood, Mo.) (3) (4) (5) . In a previous study, we demonstrated that the BTS system accurately identified 98% of patients determined by clinical parameters to have significant urinary tract infections, regardless of the number of organisms present in their urine specimens (3) . However, 45% of the specimens from noninfected patients had positive BTS readings in that study. Although most of the specimens from these patients had low positive readings, we demonstrated that if the threshold for a positive value was increased, the test sensitivity for infected patients would be reduced to an unacceptable level.
In an effort to remedy the problem with low specificity, the manufacturer has modified the decolorizing reagent used for this system. They accomplished this by decreasing the pH of the 2.4% acetic acid reagent from 4 sensitivity of this system for detecting clinically significant bacteriuria with small numbers of organisms could not be determined from these studies. Therefore, the performance of the FiltraCheck-UTI system with specimens collected from patients classified by clinical parameters as infected or noninfected was compared with that of the two automated screening systems.
MATERIALS AND METHODS
Specimens. A total of 500 randomly collected urine specimens were processed. All specimens were collected in sterile containers without urine preservatives, transported immediately to the laboratory, and processed within 2 h pad encased in a plastic disk with a 2.5-mm orifice in the center of the disk. Two drops of urine are mixed with six drops of hydrochloric acid decolorizer (pH 1.5) in a disposable dilution cup and then poured into the central well of the FiltraCheck-UTI disk. After the diluted, acidified urine is allowed to adsorb to the filter pad, 3 drops of safranin dye are added, followed by two sequential washes with 3 drops of 2.4% acetic acid (pH 3.0) decolorizer. After the reagents have adsorbed to the filter pad, the color retained in the center of the disk is compared with the color guide (similar to the manual system initially used with the BTS system). Negative and weak positive values are considered negative, and values of 1+ to 4+ are considered positive. Gram stains. Each urine specimen was mixed, and 1 drop was Gram stained and examined under 1,000x magnification. A minimum of 20 microscopic fields were examined, and the average number of organisms per field was recorded. The stain was considered to be positive if one or more organisms were seen per microscopic field.
Clinical diagnosis of urinary tract infections. Clinical histories were reviewed for all patients with >102 uropathogens per ml of urine isolated in cultures, an abnormal urinalysis, a positive Gram stain, or a positive result with any of the three urine screening tests (3) . Information recorded after review of each patient's medical record included the initial complaint and the presence of specific signs and symptoms of a urinary tract infection: dysuria, frequency, urgency, flank pain, abdominal pain, foul-smelling urine, urethral discharge, hematuria, fever, and abnormal urinalysis. Patients were classified into one of three groups: probable infection-those patients with symptoms suggestive of infection and with no alternative diagnosis; possible infectionthose patients with symptoms suggestive of infection but with an alternative diagnosis; and noninfected patientsthose patients with no abnormal urinary tract signs or symptoms and with a normal urinalysis. Patients with asymptomatic bacteriuria (2105 uropathogens per ml of urine) were classified as having probable infections.
RESULTS
Specimens from 500 patients were tested. A total of 235 (56.6%) specimens were midstream urine specimens, and 180 (43.4%) were catheter urine specimens. The method of collection was not specified for 85 specimens. Specimens were collected from 320 female and 180 male patients. Eighty-five percent of the specimens were received from inpatients.
Each The frequency of false-positive results with specimens from noninfected patients was substantially reduced from 34% with BTS-O to 13% with BTS-M and 11% with the FiltraCheck-UTI test. It is important to note that this was accomplished without compromising the test sensitivity. The differences among the three screening systems are revealed by an examination of the results for urine specimens from patients in each clinical category ( Fig. 1 to 3) . The BTS-O readings (Fig. 1) were higher for all three clinical categories than were the BTS-M readings (Fig. 2) . Likewise, the majority of patients with probable infections were easily separated from noninfected patients by the FiltraCheck-UTI screening test (Fig. 3) .
A total of 82% of the patients with probable infections had positive Gram stains (Table 1) . Although this relatively low sensitivity precluded the use of the Gram stain as a screening test, a positive Gram stain may provide additional information that would be useful for patient management. The incidence of positive Gram stains for all screening testpositive specimens (including both true-positive and falsepositive specimens) is summarized in laboratory and are frequently negative, a variety of screening tests have been developed. Although most of these tests are slow and insensitive for low-grade, clinically signficiant bacteriuria, we demonstrated in a previous study that the BTS system was a sensitive, rapid screening test for patients with symptomatic and asymptomatic infections, even when small numbers of organisms were responsible for disease (3). Unfortunately, many specimens from noninfected patients were positive with this screening test. Thus, the predictive value of a positive result was low. The practical consequence of this is the confusion that a positive screening test result creates for the patient's physician. In an effort to remedy this problem, the manufacturer has adjusted the acetic acid decolorizer solution from pH 4 to pH 3. This relatively minor change has significantly improved the performance of the test, as reported in the current study (Table  3) . When the BTS-M system was compared with the BTS-O 
